F&FFinancial Insights

Financial Metrics

ULS UL Solutions Inc.
Range: 2016-01-01 to 2026-04-29
Chart Range:
% Change:

Financial Statements

Grouped by statement

Income Statement

Metrics: 6

Revenue

Q: 9 | A: 4

Quarterly

Annual

Show Data Rows
Frequency Period End Value % Chg Unit Form Filed
Quarterly 2023-03-31 629000000.0 USD 10-Q 2024-05-20
Quarterly 2023-06-30 689000000.0 +9.5% USD 10-Q 2024-07-31
Quarterly 2023-09-30 676000000.0 -1.9% USD 10-Q 2024-11-05
Quarterly 2024-03-31 670000000.0 -0.9% USD 10-Q 2025-05-06
Quarterly 2024-06-30 730000000.0 +9.0% USD 10-Q 2025-08-05
Quarterly 2024-09-30 731000000.0 +0.1% USD 10-Q 2025-11-04
Quarterly 2025-03-31 705000000.0 -3.6% USD 10-Q 2025-05-06
Quarterly 2025-06-30 776000000.0 +10.1% USD 10-Q 2025-08-05
Quarterly 2025-09-30 783000000.0 +0.9% USD 10-Q 2025-11-04
Annual 2022-12-31 2520000000.0 USD 10-K 2025-02-20
Annual 2023-12-31 2678000000.0 +6.3% USD 10-K 2026-02-19
Annual 2024-12-31 2870000000.0 +7.2% USD 10-K 2026-02-19
Annual 2025-12-31 3053000000.0 +6.4% USD 10-K 2026-02-19

Gross Profit

Q: 0 | A: 0

Quarterly

Annual

Show Data Rows
Frequency Period End Value % Chg Unit Form Filed

Operating Income

Q: 9 | A: 4

Quarterly

Annual

Show Data Rows
Frequency Period End Value % Chg Unit Form Filed
Quarterly 2023-03-31 75000000.0 USD 10-Q 2024-05-20
Quarterly 2023-06-30 117000000.0 +56.0% USD 10-Q 2024-07-31
Quarterly 2023-09-30 89000000.0 -23.9% USD 10-Q 2024-11-05
Quarterly 2024-03-31 91000000.0 +2.2% USD 10-Q 2025-05-06
Quarterly 2024-06-30 126000000.0 +38.5% USD 10-Q 2025-08-05
Quarterly 2024-09-30 130000000.0 +3.2% USD 10-Q 2025-11-04
Quarterly 2025-03-31 109000000.0 -16.2% USD 10-Q 2025-05-06
Quarterly 2025-06-30 139000000.0 +27.5% USD 10-Q 2025-08-05
Quarterly 2025-09-30 156000000.0 +12.2% USD 10-Q 2025-11-04
Annual 2022-12-31 412000000.0 USD 10-K 2025-02-20
Annual 2023-12-31 368000000.0 -10.7% USD 10-K 2026-02-19
Annual 2024-12-31 462000000.0 +25.5% USD 10-K 2026-02-19
Annual 2025-12-31 522000000.0 +13.0% USD 10-K 2026-02-19

Net Income

Q: 9 | A: 4

Quarterly

Annual

Show Data Rows
Frequency Period End Value % Chg Unit Form Filed
Quarterly 2023-03-31 58000000.0 USD 10-Q 2024-05-20
Quarterly 2023-06-30 99000000.0 +70.7% USD 10-Q 2024-07-31
Quarterly 2023-09-30 57000000.0 -42.4% USD 10-Q 2024-11-05
Quarterly 2024-03-31 60000000.0 +5.3% USD 10-Q 2025-05-06
Quarterly 2024-06-30 106000000.0 +76.7% USD 10-Q 2025-08-05
Quarterly 2024-09-30 94000000.0 -11.3% USD 10-Q 2025-11-04
Quarterly 2025-03-31 71000000.0 -24.5% USD 10-Q 2025-05-06
Quarterly 2025-06-30 97000000.0 +36.6% USD 10-Q 2025-08-05
Quarterly 2025-09-30 106000000.0 +9.3% USD 10-Q 2025-11-04
Annual 2022-12-31 309000000.0 USD 10-K 2025-02-20
Annual 2023-12-31 276000000.0 -10.7% USD 10-K 2026-02-19
Annual 2024-12-31 345000000.0 +25.0% USD 10-K 2026-02-19
Annual 2025-12-31 345000000.0 +0.0% USD 10-K 2026-02-19

EPS Basic

Q: 9 | A: 4

Quarterly

Annual

Show Data Rows
Frequency Period End Value % Chg Unit Form Filed
Quarterly 2023-03-31 0.28 USD/shares 10-Q 2024-05-20
Quarterly 2023-06-30 0.47 +67.9% USD/shares 10-Q 2024-07-31
Quarterly 2023-09-30 0.27 -42.6% USD/shares 10-Q 2024-11-05
Quarterly 2024-03-31 0.28 +3.7% USD/shares 10-Q 2025-05-06
Quarterly 2024-06-30 0.51 +82.1% USD/shares 10-Q 2025-08-05
Quarterly 2024-09-30 0.44 -13.7% USD/shares 10-Q 2025-11-04
Quarterly 2025-03-31 0.34 -22.7% USD/shares 10-Q 2025-05-06
Quarterly 2025-06-30 0.45 +32.4% USD/shares 10-Q 2025-08-05
Quarterly 2025-09-30 0.5 +11.1% USD/shares 10-Q 2025-11-04
Annual 2022-12-31 1.47 USD/shares 10-K 2025-02-20
Annual 2023-12-31 1.3 -11.6% USD/shares 10-K 2026-02-19
Annual 2024-12-31 1.63 +25.4% USD/shares 10-K 2026-02-19
Annual 2025-12-31 1.62 -0.6% USD/shares 10-K 2026-02-19

EPS Diluted

Q: 9 | A: 4

Quarterly

Annual

Show Data Rows
Frequency Period End Value % Chg Unit Form Filed
Quarterly 2023-03-31 0.28 USD/shares 10-Q 2024-05-20
Quarterly 2023-06-30 0.47 +67.9% USD/shares 10-Q 2024-07-31
Quarterly 2023-09-30 0.27 -42.6% USD/shares 10-Q 2024-11-05
Quarterly 2024-03-31 0.28 +3.7% USD/shares 10-Q 2025-05-06
Quarterly 2024-06-30 0.5 +78.6% USD/shares 10-Q 2025-08-05
Quarterly 2024-09-30 0.44 -12.0% USD/shares 10-Q 2025-11-04
Quarterly 2025-03-31 0.33 -25.0% USD/shares 10-Q 2025-05-06
Quarterly 2025-06-30 0.45 +36.4% USD/shares 10-Q 2025-08-05
Quarterly 2025-09-30 0.49 +8.9% USD/shares 10-Q 2025-11-04
Annual 2022-12-31 1.47 USD/shares 10-K 2025-02-20
Annual 2023-12-31 1.3 -11.6% USD/shares 10-K 2026-02-19
Annual 2024-12-31 1.62 +24.6% USD/shares 10-K 2026-02-19
Annual 2025-12-31 1.6 -1.2% USD/shares 10-K 2026-02-19

8-K Material Event Details

16 filings · 40 item records

This 8-K section tracks corporate event disclosures, not insider buy/sell sentiment. Insider trading direction is shown in the insider section below.

Event Type Distribution

Count per 8-K item

Insider Transaction History

83 transaction records

Net Insider Flow

Monthly open-market buy value minus open-market sell value

Monthly Insider Activity Mix

Share volume split between open-market trades, grants, and exercises

Transaction Value Timeline

Each circle = one priced transaction; size ∝ value

All Transactions

Date Insider Title Type Security Shares Price Total Value Post-Tx Shares
2026-04-03 THAMAN MICHAEL H Equity grant / award
A · derivative
Deferred Stock Units 358 $0.00 $0 358
2026-04-01 Uggetti Alberto EVP & CCO Equity grant / award
A · derivative
Restricted Stock Units 2,287 $0.00 $0 2,287
2026-04-01 Uggetti Alberto EVP & CCO Exercise / conversion
M · derivative
Restricted Stock Units 944 $0.00 $0 1,890
2026-04-01 Uggetti Alberto EVP & CCO Other disposed transaction
F
Class A Common Stock 616 $83.80 $51,621 15,543
2026-04-01 Uggetti Alberto EVP & CCO Equity grant / award
A
Class A Common Stock 2,608 $83.80 $218,550 16,159
2026-04-01 Uggetti Alberto EVP & CCO Other disposed transaction
F
Class A Common Stock 223 $83.80 $18,687 13,551
2026-04-01 Uggetti Alberto EVP & CCO Exercise / conversion
M
Class A Common Stock 944 13,774
2026-03-12 WILLIAMS GEORGE A Equity grant / award
A · derivative
Deferred Restricted Stock Units 4 $0.00 $0 2,805
2026-03-12 WILLIAMS GEORGE A Equity grant / award
A · derivative
Deferred Restricted Stock Units 8 $0.00 $0 4,962
2026-03-03 Dadakis Alex See Remarks Exercise / conversion
M · derivative
Restricted Stock Units 5,332 $0.00 $0 10,672
2026-03-03 Dadakis Alex See Remarks Other disposed transaction
F
Class A Common Stock 1,621 $82.28 $133,376 4,062
2026-03-03 Dadakis Alex See Remarks Exercise / conversion
M
Class A Common Stock 5,332 5,683
2026-03-01 Uggetti Alberto EVP & CCO Exercise / conversion
M · derivative
Stock Appreciation Right 4,374 $0.00 $0 0
2026-03-01 Uggetti Alberto EVP & CCO Other disposed transaction
F
Class A Common Stock 1,589 $83.97 $133,428 12,830
2026-03-01 Uggetti Alberto EVP & CCO Exercise / conversion
M
Class A Common Stock 4,374 $13.15 $57,518 14,419
2026-01-05 Robinson Ryan D Executive VP & CFO Equity grant / award
G
Class A Common Stock 135,956 $0.00 $0 135,956
2026-01-02 Uggetti Alberto EVP & CCO Other disposed transaction
F
Class A Common Stock 247 $79.26 $19,577 10,045
2026-01-01 Uggetti Alberto EVP & CCO Exercise / conversion
M · derivative
Restricted Stock Units 1,007 $0.00 $0 2,023
2026-01-01 Uggetti Alberto EVP & CCO Exercise / conversion
M
Class A Common Stock 1,007 10,292
2025-12-19 ULSE Inc. Exercise / conversion
C · derivative
Class B Common Stock 1,875,000 $0.00 $0 123,755,000
2025-12-19 ULSE Inc. Open-market sell
S
Class A Common Stock 1,875,000 $78.00 $146,250,000 0
2025-12-19 ULSE Inc. Exercise / conversion
C
Class A Common Stock 1,875,000 1,875,000
2025-12-08 Hecker Friedrich Equity grant / award
A · derivative
Restricted Stock Units 4 $0.00 $0 2,801
2025-12-05 ULSE Inc. Exercise / conversion
C · derivative
Class B Common Stock 12,500,000 $0.00 $0 125,630,000
2025-12-05 ULSE Inc. Open-market sell
S
Class A Common Stock 12,500,000 $78.00 $975,000,000 0
2025-12-05 ULSE Inc. Exercise / conversion
C
Class A Common Stock 12,500,000 12,500,000
2025-10-03 Shannon James M Equity grant / award
A · derivative
Deferred Stock Units 203 $0.00 $0 1,443
2025-09-08 D'Angelo Scott EVP, CLO & Corporate Secy Equity grant / award
A · derivative
Restricted Stock Units 7 $0.00 $0 3,581
2025-09-08 D'Angelo Scott EVP, CLO & Corporate Secy Equity grant / award
A · derivative
Restricted Stock Units 17 $0.00 $0 8,595
2025-09-08 SUSMAN SALLY Equity grant / award
A · derivative
Deferred Restricted Stock Unit 5 $0.00 $0 2,797
2025-09-08 SUSMAN SALLY Equity grant / award
A · derivative
Deferred Restricted Stock Unit 10 $0.00 $0 4,946
2025-07-02 Shannon James M Equity grant / award
A · derivative
Deferred Stock Units 189 $0.00 $0 1,240
2025-06-09 D'Angelo Scott EVP, CLO & Corporate Secy Equity grant / award
A · derivative
Restricted Stock Units 6 $0.00 $0 3,574
2025-06-09 D'Angelo Scott EVP, CLO & Corporate Secy Equity grant / award
A · derivative
Restricted Stock Units 15 $0.00 $0 8,578
2025-05-20 Kini Vikram Equity grant / award
A · derivative
Restricted Stock Unit 2,787 $0.00 $0 2,787
2025-05-09 Schjotz Gitte See Remarks Exercise / conversion
M · derivative
Stock Appreciation Right 19,664 $0.00 $0 0
2025-05-09 Schjotz Gitte See Remarks Other disposed transaction
F
Class A Common Stock 8,425 $70.17 $591,182 58,128
2025-05-09 Schjotz Gitte See Remarks Exercise / conversion
M
Class A Common Stock 19,664 $30.06 $591,100 66,553
2025-05-08 Uggetti Alberto EVP & CCO Open-market sell
S
Class A Common Stock 1,961 $70.00 $137,270 9,285
2025-05-07 Schjotz Gitte See Remarks Open-market sell
S
Class A Common Stock 7,000 $67.44 $472,080 46,889
2025-05-01 THAMAN MICHAEL H Exercise / conversion
M · derivative
Dividend Equivalent Rights 49 $0.00 $0 0
2025-05-01 THAMAN MICHAEL H Exercise / conversion
M · derivative
Restricted Stock Unit 4,878 $0.00 $0 0
2025-05-01 THAMAN MICHAEL H Exercise / conversion
M
Class A Common Stock 49 13,855
2025-05-01 THAMAN MICHAEL H Exercise / conversion
M
Class A Common Stock 4,878 13,806
2025-05-01 Zhou Weifang See Remarks Other disposed transaction
F
Class A Common Stock 1,958 $58.39 $114,328 46,361
2025-04-04 Shannon James M Equity grant / award
A · derivative
Deferred Stock Units 235 $0.00 $0 1,051
2025-04-01 Uggetti Alberto EVP & CCO Equity grant / award
A · derivative
Restricted Stock Units 2,826 $0.00 $0 2,826
2025-04-01 Robinson Ryan D Executive VP & CFO Exercise / conversion
M · derivative
Stock Appreciation Right 31,810 $0.00 $0 0
2025-04-01 Robinson Ryan D Executive VP & CFO Equity grant / award
A · derivative
Restricted Stock Units 9,218 $0.00 $0 9,218
2025-04-01 Robinson Ryan D Executive VP & CFO Other disposed transaction
F
Class A Common Stock 3,709 $57.85 $214,566 133,267
2025-04-01 Robinson Ryan D Executive VP & CFO Equity grant / award
A
Class A Common Stock 8,371 $57.85 $484,262 136,976
2025-04-01 Robinson Ryan D Executive VP & CFO Other disposed transaction
F
Class A Common Stock 17,461 $57.85 $1,010,119 128,605
2025-04-01 Robinson Ryan D Executive VP & CFO Exercise / conversion
M
Class A Common Stock 31,810 $13.15 $418,302 146,066
2025-03-10 Hooper Charles W Equity grant / award
A · derivative
Dividend Equivalent Rights 12 $0.00 $0 49
2025-03-07 Uggetti Alberto EVP & CCO Open-market sell
S
Class A Common Stock 1,938 $53.00 $102,714 9,285
2025-03-03 Dadakis Alex See Remarks Equity grant / award
A · derivative
Restricted Stock Unit 15,917 $0.00 $0 15,917
2025-01-06 Shannon James M Dir Equity grant / award
A · derivative
Deferred Stock Units 261 $0.00 $0 816
2025-01-01 Schjotz Gitte See Remarks Equity grant / award
A · derivative
Restricted Stock Unit 5,012 $0.00 $0 5,012
2024-12-12 Schjotz Gitte See Remarks Open-market sell
S
Class A Common Stock 21,000 $51.14 $1,074,039 45,273
2024-12-11 Schjotz Gitte See Remarks Open-market sell
S
Class A Common Stock 192 $52.63 $10,105 66,273
2024-12-10 Schjotz Gitte See Remarks Open-market sell
S
Class A Common Stock 2,726 $52.58 $143,336 66,465
2024-12-09 Chapin Linda S EVP & CHRO Equity grant / award
A · derivative
Dividend Equivalent Rights 10 $0.00 $0 34
2024-12-06 Schjotz Gitte See Remarks Exercise / conversion
M · derivative
Stock Appreciation Right 24,850 $0.00 $0 0
2024-12-06 Schjotz Gitte See Remarks Other disposed transaction
D
Class A Common Stock 12,250 $53.35 $653,538 75,132
2024-12-06 Schjotz Gitte See Remarks Exercise / conversion
M
Class A Common Stock 49,700 $13.15 $653,555 87,382
2024-12-06 Schjotz Gitte See Remarks Open-market sell
S
Class A Common Stock 1,466 $54.50 $79,897 37,682
2024-10-25 Scanlon Jennifer F. President and CEO Equity grant / award
G
Class A Common Stock 89,285 $0.00 $0 89,285
2024-10-03 Shannon James M Dir Equity grant / award
A · derivative
Deferred Stock Units 257 $0.00 $0 555
2024-10-01 Scanlon Jennifer F. President and CEO Exercise / conversion
M · derivative
Stock Appreciation Right 42,974 $0.00 $0 0
2024-10-01 Scanlon Jennifer F. President and CEO Other disposed transaction
F
Class A Common Stock 31,732 $49.16 $1,559,945 100,527
2024-10-01 Scanlon Jennifer F. President and CEO Exercise / conversion
M
Class A Common Stock 42,974 $26.07 $1,120,332 132,259
2024-09-23 ULSE Inc. 10% Exercise / conversion
C · derivative
Class B Common Stock 3,000,000 $0.00 $0 138,130,000
2024-09-23 ULSE Inc. 10% Open-market sell
S
Class A Common Stock 3,000,000 $49.00 $147,000,000 0
2024-09-23 ULSE Inc. 10% Exercise / conversion
C
Class A Common Stock 3,000,000 3,000,000
2024-09-09 Schjotz Gitte See Remarks Equity grant / award
A · derivative
Dividend Equivalent Rights 20 $0.00 $0 44
2024-07-03 Shannon James M Dir Equity grant / award
A · derivative
Deferred Stock Units 298 $0.00 $0 298
2024-06-18 Genovesi John A See Remarks Equity grant / award
A · derivative
Dividend Equivalent Rights 17 $0.00 $0 17
2024-05-21 DOLLIVE JAMES P Dir Equity grant / award
A · derivative
Restricted Stock Unit 4,878 $0.00 $0 4,878
2024-05-01 SUSMAN SALLY Equity grant / award
A · derivative
Deferred Restricted Stock Unit 4,878 $0.00 $0 4,878
2024-05-01 Zhou Weifang See Remarks Equity grant / award
A · derivative
Restricted Stock Unit 13,868 $0.00 $0 13,868
2024-04-16 ULSE Inc. 10% Exercise / conversion
C · derivative
Class B Common Stock 38,870,000 $0.00 $0 161,130,000
2024-04-16 ULSE Inc. 10% Open-market sell
S
Class A Common Stock 38,870,000 $28.00 $1,088,360,000 0
2024-04-16 ULSE Inc. 10% Exercise / conversion
C
Class A Common Stock 38,870,000 38,870,000

Regulatory Activity

Last 12 months to 2025-04-29
Insider Filings (Forms 3/4/5) — 12 months
23
Material Event Filings (8-K) — 12 months
8

8-K Material Event Filing Activity

Monthly count

Insider Trading Activity (Forms 3/4/5)

Monthly count
For informational purposes only — not guaranteed to be accurate or complete.